Juan C. Jaen insider trades: Arcus Biosciences (RCUS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Juan reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | RCUS | ↓ Sell10b5-1 | 68,569 | $29.63 | $2.0M | By Trust | Jul 13, 2026 (3d) |
| Jun 24, 2026 | RCUS | ↓ Sell | 31,431 | $27.92 | $878K | By Trust | Jun 24, 2026 (0d) |
| Jan 5, 2026 | RCUS | ↓ Sell10b5-1 | 31,823 | $21.41 | $681K | By Trust | Jan 7, 2026 (2d) |
| Dec 17, 2025 | RCUS | ↓ Sell | 21,208 | $22.01 | $467K | Direct | Dec 18, 2025 (1d) |
| Dec 4, 2025 | RCUS | ↓ Sell10b5-1 | 82,997 | $24.71 | $2.1M | By Trust | Dec 5, 2025 (1d) |
| Nov 18, 2025 | RCUS | ↓ Sell10b5-1 | 50,000 | $20.26 | $1.0M | By Trust | Nov 19, 2025 (1d) |
| Oct 30, 2025 | RCUS | ↓ Sell10b5-1 | 4,314 | $20.32 | $88K | By Trust | Nov 3, 2025 (4d) |
| Oct 29, 2025 | RCUS | ↓ Sell10b5-1 | 96,859 | $20.76 | $2.0M | By Trust | Oct 30, 2025 (1d) |
| Feb 27, 2024 | RCUS | ↓ Sell10b5-1 | 27,032 | $20.09 | $543K | By Trust | Feb 28, 2024 (1d) |
| Jan 2, 2024 | RCUS | ↓ Sell10b5-1 | 6,975 | $20.09 | $140K | By Trust | Jan 4, 2024 (2d) |
| Dec 16, 2022 | RCUS | ↓ Sell | 4,436 | $30.75 | $136K | Direct | Dec 16, 2022 (0d) |
| Jun 17, 2022 | RCUS | ↓ Sell | 4,870 | $21.45 | $104K | Direct | Jun 21, 2022 (4d) |
| Dec 17, 2021 | RCUS | ↓ Sell | 1,973 | $40.12 | $79K | Direct | Dec 20, 2021 (3d) |
| Jun 17, 2021 | RCUS | ↓ Sell | 4,857 | $23.89 | $116K | Direct | Jun 21, 2021 (4d) |
| Jun 28, 2019 | RCUS | ↑ Buy | 15,000 | $7.59 | $114K | By Trust | Jun 28, 2019 (0d) |
| Jun 3, 2019 | RCUS | ↑ Buy | 10,000 | $8.25 | $82K | By Trust | Jun 4, 2019 (1d) |
| Nov 13, 2018 | RCUS | ↑ Buy | 10,000 | $11.80 | $118K | By Trust | Nov 15, 2018 (2d) |
| Aug 13, 2018 | RCUS | ↑ Buy | 10,000 | $11.88 | $119K | By Trust | Aug 13, 2018 (0d) |
| Mar 19, 2018 | RCUS | ↑ Buy | 66,666 | $15.00 | $1000K | By Trust | Mar 19, 2018 (0d) |
| Mar 8, 2013 | CCXI | ↓ Sell | 2,795 | $13.97 | $39K | Direct | Mar 11, 2013 (3d) |
| Mar 6, 2013 | CCXI | ↓ Sell | 12,205 | $13.97 | $170K | Direct | Mar 6, 2013 (0d) |
| Feb 28, 2013 | CCXI | ↓ Sell | 12,599 | $12.79 | $161K | Direct | Mar 1, 2013 (1d) |
| Feb 26, 2013 | CCXI | ↓ Sell | 22,500 | $12.23 | $275K | Direct | Feb 26, 2013 (0d) |
| Feb 21, 2013 | CCXI | ↓ Sell | 22,201 | $11.90 | $264K | Direct | Feb 21, 2013 (0d) |
| Feb 15, 2013 | CCXI | ↓ Sell | 1,945 | $11.74 | $23K | Direct | Feb 19, 2013 (4d) |
| Feb 7, 2013 | CCXI | ↓ Sell | 1,555 | $11.65 | $18K | Direct | Feb 8, 2013 (1d) |
| Feb 4, 2013 | CCXI | ↓ Sell | 3,875 | $11.69 | $45K | Direct | Feb 6, 2013 (2d) |
| Feb 1, 2013 | CCXI | ↓ Sell | 10,005 | $11.58 | $116K | Direct | Feb 1, 2013 (0d) |
| Jan 29, 2013 | CCXI | ↓ Sell | 7,698 | $11.43 | $88K | Direct | Jan 29, 2013 (0d) |
| Jan 24, 2013 | CCXI | ↓ Sell | 1,300 | $11.35 | $15K | Direct | Jan 24, 2013 (0d) |
| Jan 12, 2013 | CCXI | ↓ Sell | 3,305 | $11.35 | $38K | Direct | Jan 15, 2013 (3d) |
| Jan 4, 2013 | CCXI | ↓ Sell | 6,017 | $11.27 | $68K | Direct | Jan 4, 2013 (0d) |
| Dec 18, 2012 | CCXI | ↓ Sell | 15,000 | $11.05 | $166K | Direct | Dec 19, 2012 (1d) |
| Nov 14, 2012 | CCXI | ↓ Sell | 2,000 | $12.95 | $26K | Direct | Nov 16, 2012 (2d) |
| Nov 6, 2012 | CCXI | ↓ Sell | 5,833 | $12.01 | $70K | Direct | Nov 8, 2012 (2d) |
| Oct 1, 2012 | CCXI | ↓ Sell | 2,400 | $11.98 | $29K | Direct | Oct 1, 2012 (0d) |
| Sep 25, 2012 | CCXI | ↓ Sell | 7,401 | $11.96 | $88K | Direct | Sep 27, 2012 (2d) |
| Sep 24, 2012 | CCXI | ↓ Sell | 3,566 | $11.97 | $43K | Direct | Sep 24, 2012 (0d) |
| Sep 17, 2012 | CCXI | ↓ Sell | 800 | $12.05 | $10K | Direct | Sep 19, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RCUS insiders
Open-market trades in the last 12 months
About Juan C. Jaen's insider trades
Juan C. Jaen is President at Arcus Biosciences (RCUS). Since Sep 17, 2012, Juan has reported 5 open-market purchases worth $1.4M and 34 sales worth $12.1M on SEC Form 4. In the last 12 months: 6 sales ($7.1M).
8 sales (71% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (12 filings), option exercises (12 filings), gifts (3 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCUS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.